Tech Company Financing Transactions

Aetion Funding Round

Aetion, based in New York, secured $27 million in investment from Amgen Ventures, Flare Capital Partners and Horizon Healthcare Services.

Transaction Overview

Company Name
Aetion
Announced On
2/6/2019
Transaction Type
Venture Equity
Amount
$27,000,000
Round
Undisclosed
Investors

Amgen Ventures (Elliott Levy)

Flare Capital Partners (William Geary)

Horizon Healthcare Services (William Georges)

Lakestar

McKesson Ventures (Thomas Rodgers)

New Enterprise Associates (Mohamad Makhzoumi)

Sanofi-Genzyme BioVentures (Ameet Nathwani)

UCB S.A. (Iris Loew-Friedrich)

Proceeds Purpose
Investment funds will be applied to strengthen the Aetion Evidence Platform, extending its reach in therapeutic area-related intelligence, outcomes-based contracting for payers, and advancing the acceptance of standards for real-world evidence around the globe.

Company Information

Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
5 Penn Plaza 7th Floor
New York, NY 10001
USA
Phone
(844) 823-8466
Website
www.aetion.com
Email Address
[email protected]
Overview
Aetion was founded in 2013 by Harvard Medical School faculty members Sebastian Schneeweiss and Jeremy A. Rassen and big data technologist Allon Rauer. We were founded on a simple truth: the need for essential evidence to support value-based healthcare was scaling far faster than existing mechanisms could generate it.
Profile
Aetion LinkedIn Company Profile
Social Media
Aetion Company Twitter Account
Company News
Aetion News
Facebook
Aetion on Facebook
YouTube
Aetion on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Carolyn Magill
  Carolyn Magill LinkedIn Profile  Carolyn Magill Twitter Account  Carolyn Magill News  Carolyn Magill on Facebook
Chief Financial Officer
TC Fleming
  TC Fleming LinkedIn Profile  TC Fleming Twitter Account  TC Fleming News  TC Fleming on Facebook
Chief Marketing Officer
Elizabeth DeMatteis
  Elizabeth DeMatteis LinkedIn Profile  Elizabeth DeMatteis Twitter Account  Elizabeth DeMatteis News  Elizabeth DeMatteis on Facebook
Chief Scientific Officer
Jeremy Rassen
  Jeremy Rassen LinkedIn Profile  Jeremy Rassen Twitter Account  Jeremy Rassen News  Jeremy Rassen on Facebook
Chief Technical Officer
John Turek
  John Turek LinkedIn Profile  John Turek Twitter Account  John Turek News  John Turek on Facebook
Co-Founder
Sebastian Schneeweiss
  Sebastian Schneeweiss LinkedIn Profile  Sebastian Schneeweiss Twitter Account  Sebastian Schneeweiss News  Sebastian Schneeweiss on Facebook
Vice President
Julie Schiffman
  Julie Schiffman LinkedIn Profile  Julie Schiffman Twitter Account  Julie Schiffman News  Julie Schiffman on Facebook
VP - Bus. Development
Richard Jenkins
  Richard Jenkins LinkedIn Profile  Richard Jenkins Twitter Account  Richard Jenkins News  Richard Jenkins on Facebook
VP - General Counsel
Lori Bennett
  Lori Bennett LinkedIn Profile  Lori Bennett Twitter Account  Lori Bennett News  Lori Bennett on Facebook
VP - Human Resources
David Vavrasek
  David Vavrasek LinkedIn Profile  David Vavrasek Twitter Account  David Vavrasek News  David Vavrasek on Facebook
VP - R & D
Nicolle Gatto
  Nicolle Gatto LinkedIn Profile  Nicolle Gatto Twitter Account  Nicolle Gatto News  Nicolle Gatto on Facebook
VP - Regulatory Affairs
Lowell Schiller
  Lowell Schiller LinkedIn Profile  Lowell Schiller Twitter Account  Lowell Schiller News  Lowell Schiller on Facebook

 

 

Browse more venture capital transactions:

Prev: 2/6/2019: SmartSky Networks venture capital transaction
Next: 2/6/2019: CathWorks venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to record every notable VC transaction. VC investment data records reported here are derived from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.